This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Castro EC, Blazquez C, Boyd J, Correa H, de Chadarevian JP, Felgar RE et al. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol 2010; 13: 225–237.
Tijchon E, Havinga J, van Leeuwen FN, Scheijen B . B-lineage transcription factors and cooperating gene lesions required for leukemia development. Leukemia 2013; 27: 541–552.
Simmons S, Knoll M, Drewell C, Wolf I, Mollenkopf HJ, Bouquet C et al. Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development. Blood 2012; 120: 3688–3698.
Greaves MF . Differentiation-linked leukemogenesis in lymphocytes. Science 1986; 234: 697–704.
Cobaleda C, Busslinger M . Developmental plasticity of lymphocytes. Curr Opin Immunol 2008; 20: 139–148.
Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grümayer R, Möricke A et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 2010; 115: 3206–3214.
Ivan D, Neto A, Lemos L, Gupta A . Erdheim-Chester disease: a unique presentation with liver involvement and vertebral osteolytic lesions. Arch Pathol Lab Med 2003; 127: 337–339.
Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood 2013; 121: 1495–1500.
Naik SH, Perié L, Swart E, Gerlach C, van Rooij N, de Boer RJ et al. Diverse and heritable lineage imprinting of early haematopoietic progenitors. Nature 2013; 496: 229–232.
Mullighan CG, Phillips LA, Su X, Ma J, Miller CB, Shurtleff SA et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 2008; 322: 1377–1380.
Rapino F, Robles EF, Richter-Larrea JA, Kallin EM, Martinez-Climent JA, Graf T . C/EBPα induces highly efficient macrophage transdifferentiation of B lymphoma and leukemia cell lines and impairs their tumorigenicity. Cell Rep 2013; 3: 1153–1163.
Stoilova B, Kowenz-Leutz E, Scheller M, Leutz A . Lymphoid to myeloid cell trans-differentiation is determined by C/EBPβ structure and post-translational modifications. PLoS One 2013; 8: e65169.
Livak K, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402–408.
Slamova L, Starkova J, Fronkova E, Zaliova M, Reznickova L, van Delft FW et al. CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage. Leukemia 2014; 28: 609–620.
Acknowledgements
This research was partially supported by AIRC to G Cazzaniga and AB, AIRC ‘5 per mille’ to AB, and also by grants from Ministero Italiano dell’Università e della Ricerca and Ministero della Salute to AB.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Pagni, F., Fazio, G., Zannella, S. et al. The role of PAX5 and C/EBP α/β in atypical non-Langerhans cell histiocytic tumor post acute lymphoblastic leukemia. Leukemia 28, 1377–1379 (2014). https://doi.org/10.1038/leu.2014.87
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2014.87
This article is cited by
-
PAX5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution assessment using NGS-based immunoglobulin clonality and mutation analysis
Virchows Archiv (2023)
-
Independent development of lymphoid and histiocytic malignancies from a shared early precursor
Leukemia (2016)